Interlinking brain mapping and Parkinson’s disease: MRI analysis, nigrosome 1 and nigrosome 4

Eung Yeop Kim, Young Hee Sung, Jongho Lee

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The nigrosome 1 and 4 regions in the substantia nigra can be assessed separately by using high-spatial-resolution susceptibility map-weighted imaging. The nigrosome 1 region is mainly identified below the red nucleus, while the nigrosome 4 region is located at the level of the lower portion of the red nucleus on coronal-reformatted susceptibility map-weighted imaging. Each region exhibits differential involvement according to clinical stages in idiopathic Parkinson’s disease, with the nigrosome 1 region involved earlier, followed by the nigrosome 4 region. Such observations may be supported by coregistered high-spatial-resolution neuromelanin-sensitive imaging and the relationship with the extent of abnormality of dopamine transporter activity. From our results, we suggest that high-spatial-resolution susceptibility map-weighted imaging may serve not only as a diagnostic tool but also as an imaging biomarker for disease severity in idiopathic Parkinson’s disease.

Original languageEnglish
Title of host publicationGenetics, Neurology, Behavior, and Diet in Parkinson’s Disease
Subtitle of host publicationThe Neuroscience of Parkinson’s Disease, Volume 2
PublisherElsevier
Pages267-281
Number of pages15
ISBN (Electronic)9780128159507
DOIs
StatePublished - 1 Jan 2020
Externally publishedYes

Keywords

  • Dopamine transporter imaging
  • Magnetic resonance imaging
  • Neuromelanin-sensitive imaging
  • Nigrosome
  • Quantitative susceptibility mapping
  • Substantia nigra

Fingerprint

Dive into the research topics of 'Interlinking brain mapping and Parkinson’s disease: MRI analysis, nigrosome 1 and nigrosome 4'. Together they form a unique fingerprint.

Cite this